JCTLM/2017-31
Challenges of implementing JCTLM methods in the routine Clinical Laboratories
Ravinder Singh
JCTLM/2017-30
Providing traceability for protein biomarkers
Karen Phinney
JCTLM/2017-29
Certified Reference Materials for Prenatal and Neonatal Testing
Ji-Seon Jeong
JCTLM/2017-28
Certified reference materials for ensuring traceability: From experience with steroids and peptides
Akiko Takatsu
JCTLM/2017-27
HbA1c measurement by IDMS - current situation and future development
Qinde Liu
JCTLM/2017-26
Standardization of multiple serum apolipoproteins using bottom-up quantitative proteomics on behalf of the IFCC Scientific Division WG-APO MS
Christa Cobbaert
JCTLM/2017-25
The national infrastructure for traceability in laboratory medicine in China
Hongmei Li
JCTLM/2017-24
New developments in the Standardisation of Gene Amplification Techniques (SoGAT)
Neil Almond
JCTLM/2017-23
EQAs in microbiology and standardization of MRSA testing
Parviz Ahmad-Nejad
JCTLM/2017-21
LCMS methods and traceability of CSF biomarker measurements
Chiara Giangrande
JCTLM/2017-19
Role of metals and metal containing biomolecules in neurodegenerative diseases such as Alzheimer's disease
Claudia Swart
JCTLM/2017-18
Reference method for b-amyloid in CSF
Josef Pannee
JCTLM/2017-17
Preanalytical and analytical aspects of CSF biomarker assays
Armand Perret-Liaudet
JCTLM/2017-16
Potential clinical applications of biomarkers of neurodegenerative disease
Sergio Bernardini
JCTLM/2017-14
ISO 17511:2003 - Traceability of values assigned to IVD calibrators and controls: a progress report on revisions underway in ISO/TC212
Neil Greenberg
JCTLM/2017-13
Traceability and the IVD Industry: The Manufacturer s Role
Graham Beastall, David Armburster
JCTLM/2017-12
International EQA surveys for calibration laboratories
Anja Kessler
JCTLM/2017-11
How RCPAQAP ensure traceability in EQA and stress its importance to users?
Tony Badrick
JCTLM/2017-10
How ProgBA ensure traceability in EQA and stress its importance to users?
Silvia Quiroga
JCTLM/2017-09
How WEQAS ensure traceability in EQA and stress its importance to users?
David Ducroq
JCTLM/2017-08
Why traceability is important to EQA providers?
Piet Meijer
JCTLM/2017-07
Why traceability matters to patients?
Graham Jones
JCTLM/2017-06
TEP WG update: Meetings, publicity and promotion
Graham Beastall
JCTLM/2017-05
TEP WG update : Resources to explain scientific concepts
Elvar Theodorsson
JCTLM/2017-04
TEP WG update: Definitions
Robert Wielgosz
JCTLM/2017-03
The JCTLM database: developments and status
Robert Wielgosz
JCTLM/2017-02
JCTLM Update: Organization and Achievements
Gary Myers
JCTLM/2017-01
Welcome and introduction to the BIPM
James McLaren
JCTLM/2017-00
2017 Workshop Programme
